SCHEMBL14214427

SCHEMBL14214427

Cc1[nH]c2cc(C#N)ccc2c1C(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ CSNK1D P48730 5/20 0.40
▸ CSNK1G2 P78368 4/20 0.40
▸ CSNK1A1 P48729 3/20 0.40
▸ GSK3B P49841 3/20 0.40
▸ ITK Q08881 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ CYP2A6 P11509 1/20 0.38
▸ ALK Q9UM73 1/20 0.37
▸ MAPK10 P53779 1/20 0.37
▸ RIPK1 Q13546 1/20 0.37
▸ NOS3 P29474 1/20 0.37
▸ NOS1 P29475 1/20 0.37
▸ NOS2 P35228 1/20 0.37
▸ CFB P00751 2/20 0.37
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ TTK P33981 1/20 0.36
▸ KIF11 P52732 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14022011 0.80 AHR (0.47) L3MBTL1CSNK1DCSNK1G2CSNK1A1GSK3B
SCHEMBL6007662 0.74 CHUK (0.53) L3MBTL1ITKALDH1A1CYP2A6MAPK10
SCHEMBL6008260 0.74 KIF11 (0.58) L3MBTL1CSNK1DCSNK1G2CSNK1A1GSK3B
SCHEMBL28300282 0.73 ALK (0.41) L3MBTL1CSNK1DCSNK1G2CSNK1A1GSK3B
SCHEMBL10481569 0.72 KDM4E (0.49) L3MBTL1ITKALDH1A1ALKNOS3
SCHEMBL29894052 0.71 KDM4E (0.59) ALDH1A1NOS3NOS1NOS2
SCHEMBL4736477 0.71 KDM4E (0.59) ALDH1A1NOS3NOS1NOS2
SCHEMBL13243050 0.70 ITK (0.41) L3MBTL1CSNK1DCSNK1G2CSNK1A1GSK3B
SCHEMBL14214508 0.70 AHR (0.57) L3MBTL1ALDH1A1MEN1KMT2AKIF11
SCHEMBL12377872 0.69 SLC6A4 (0.48) ITKALDH1A1CYP2A6MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080103130-A1 7-hydroxy-6-{[1-methyl-3-(1,3-thiazol-5-yl)propyl]amino}-4,5,6,7-tetrahydroimidazo[4,5,1-jk][1]benzazepin-2(1H)-one; agonists at the beta-2 adrenoceptor; feed additives for livestock animals; improving meat yield or meat quality PFIZER LIMITED (GB) 2008-05-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080103130-A1 7-hydroxy-6-{[1-methyl-3-(1,3-thiazol-5-yl)propyl]amino}-4,5,6,7-tetrahydroimidazo[4,5,1-jk][1]benzazepin-2(1H)-one; agonists at the beta-2 adrenoceptor; feed additives for livestock animals; improving meat yield or meat quality ADRB2, ADRB1, ADRA2C L3MBTL1 3143/4885CSNK1D 49/4885CSNK1G2 123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback